Modern and Automated Facilities
Our brand new, state-of-the-art facilities include R&D labs for cell line development, USP and DSP processes establishment, and analytical support. cGMP manufacturing site with both single-use and stainless steel systems for upstream and downstream process development, formulation, and fill-finish of microbial and mammalian cell culture-based products will be fully functional in 2021. Flexible design with integrated infrastructure enables us to develop, formulate, and manufacture clients’ proteins and antibodies quite fast while aseptic drug product manufacturing capabilities allows adding value to customer project from timelines and cost perspective.
The microbial production line consists of 30L-300L fermenters and mammalian line comprises various single-use bioreactors ranging from 10L to 2000L, with possibility to expand capacity with second 2000L bioreactor.
We are a 30 min drive from the Logan International Airport, which can be easily accessed from all major US cities and many international locations.